- 基本信息
|
导师姓名：
|
宗祥云
|
学科代码：
|
|
|
|
性别：
|
男
|
学科名称：
|
|
|
培养单位：
|
附属第六人民医院
|
三级学科
|
普外
|
|
导师类型：
|
博士生导师
|
专业领域名称：
|
外科学 专业学位
|
|
联系方式：
|
|
专业领域代码：
|
105111
|
|
邮编：
|
|
邮箱地址：
|
tigerzong@msn.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
| |
|
上海市中西医结合学会甲乳外科专委会委员
|
|
中国卫生产业企业管理协会外科技术创新与推广分会手术与细胞治疗学术委员会委员
|
|
教育部学位中心评审专家
|
|
《Sarcoma Research International》编委
|
|
中华医学会肿瘤学分会会员、中国抗癌协会会员、CSCO会员、ASCO会员、AACR、ASBrS会员
|
|
中国抗癌协会肿瘤代谢专业委员会青年委员
|
- 科研项目
| 22Y11912900 | 保留腋静脉属支的腋窝清扫术对于乳腺癌术后上肢水肿及功能障碍的影响：前瞻性、多中心、双盲、随机、对照研究 | 上海市科委 |
2022-07~2025-06
|
30万元
| 课题负责人 |
| 81772811 | SETD8通过FBP1调节肿瘤细胞糖代谢引起乳腺癌化疗耐药的分子机制研究 | 国家自然科学基金面上项目 |
2018-01~2021-12
|
55万元
| 课题负责人 |
| 15411966500 | GnRHa保护乳腺癌化疗患者卵巢功能的临床研究 | 上海市科委 |
2015-07~2018-09
|
10万元
| 课题负责人 |
| Y2110519 | CDK2-AP1对乳腺癌细胞增殖、侵袭性及化疗敏感性的影响研究 | 浙江省自然科学基金 |
2012-01~2014-12
|
10万元
| 课题负责人 |
| 2010QNA005 | 乳腺癌CDK2-AP1表达及其对化疗敏感性影响的研究 | 浙江省卫生厅优秀青年人才基金 |
2010-12~2013-12
|
9万元
| 课题负责人 |
- 学术论文
|
Chen X, Liu S, Peng X,
|
The roles of anti-Müllerian hormone in breast cancer.
|
Endocrine Related Cancer
|
2023
|
14;30(10):e230060.
|
|
Wen Li,Xiao Li,Zhibin Kong,Bin Chen,Hongsheng Zhou,Yimin Jiang,Weimei Li,Lichang Zhong,Xinyu Zhang,Kaihua Zhang,Lili Zhang,,Wenkun Bai*,Yuanyi Zheng*
|
Efficacy of low-intensity pulsed ultrasound in the treatment of COVID-19 pneumonia
|
Ultraschall in Med
|
2023
|
44: e274–e283
|
|
Yu Y,
|
Clinical Utility Assessment of Gonadotropin-Releasing Hormone Analogs Among Women Younger Than 35 Years-Reply.
|
JAMA Oncol
|
2022
|
8(6):1
|
|
, Yu Y, Chen W, Zong W, Yang H, Chen X.
|
Ovarian reserve in premenopausal women with breast cancer.
|
The Breast.
|
2022
|
64:143-150.
|
|
, Yu Y, Yang H, Chen W, Ding X, Liu S, Li X, Chen X, Jiang C, Xia X, Huang R, Zhu M, Hu J, Liang C.
|
Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China: A Randomized Clinical Trial.
|
JAMA Oncology
|
2022
|
8(2):252-258.
|
|
Zong W, Carver E, Zhu S, Schaff E, Chapman D, Lee J, Bagher-Ebadian H, Movsas B, Wen W, Alafif T,
|
Prostate cancer malignancy detection and localization from mpMRI using auto-deep learning as one step closer to clinical utilization.
|
Science Reports.
|
2022
|
12(1):22430.
|
|
Xiaolin Li, Sixuan Liu, Xuan Chen, Run Huang, Lisi Ma, Huaiyu Weng, Yang Yu,
|
GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
|
npj Breast Cancer
|
2021
|
7: 132
|
|
Li X, Liu S, Ma L, Chen X, Weng H, Huang R, Yu Y,
|
Can Anti-Müllerian Hormone Be a Reliable Biomarker for Assessing Ovarian Function in Women Postchemotherapy?
|
Cancer Management and Research
|
2020
|
12：8171–8181
|
|
Ma L,
|
Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis.
|
Frontiers in oncology
|
2020
|
10: 5
|
|
李晓林,俞洋,
|
促性腺激素释放激素类似物在乳腺癌治疗中的应用及前景
|
中华肿瘤杂志
|
2019
|
41(4) :246-250
|
|
Xiaolin Li, Run Huang, Lisi Ma, Sixuan Liu,
|
Locoregional surgical treatment improves the prognosis in primary metastatic breast cancer patients with a single distant metastasis except for brain metastasis
|
The Breast
|
2019
|
45:104-112
|
|
Run Huang,
|
Aberrant cancer metabolism in epithelial–mesenchymal transition and cancer metastasis: Mechanisms in cancer progression
|
Critical Reviews in Oncology/Hematology
|
2017
|
115 : 13-22
|
|
Run Huang(#),Yang Yu,,Xiaolin Li,Lisi Ma,Qi Zheng
|
Monomethyltransferase SETD8 regulates breast cancer metabolism via stabilizing hypoxia-inducible factor 1α
|
Cancer Letters
|
2017
|
390: 1-10
|
|
Run Huang, Xiaolin Li1, Yang Yu, Lisi Ma, Sixuan Liu,, Qi Zheng
|
SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis
|
Oncotarget
|
2017
|
8:94080-94090
|
|
HJ Yang(#),XF Yu,,DB Chen,XW Ding,Y Yu,DH Zou,XM He,WL Feng,J Chen,WJ Mo,C Wang
|
Goserelin plus tamoxifen versus tamoxifen alone, in pre-menopausal or peri-menopausal patients with hormone receptor-positive early-stage breast cancer: A randomised controlled trial in China
|
European Journal of Cancer
|
2016
|
60: e7-e8
|
|
Yang Yu,Run Huang,,Xiangming He,Wenju Mo
|
INFα-2b inhibitory effects on CD4+CD25+FOXP3+ regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts
|
BMC Cancer
|
2016
|
2016(16)：397
|
|
X He, H Xiang,, X Yan, Y Yu, G Liu, D Zou, H Yang.
|
CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro.
|
Cancer Cell International
|
2014
|
14(130):1-10
|
|
Yu Y, Xiang H, He XM, Yang HJ,
|
The Predictive factors in Determining Neoadjuvant Chemotherapy Outcomes in Breast Cancer—a single center experience.
|
APJCP
|
2013
|
14(4):2401-2406
|
|
H Yang*,, Y Yu, G Shao, L Zhang, C Qian, Y Bian, X Xu, W Sun, X Meng, X Ding, D Chen, D Zou, S Xie, Y Zheng, J Zhang, X He, C Sun, X Yu and J Ni.
|
Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial.
|
British Journal of Cancer
|
2013
|
109(3):582-588
|
|
YU Y, FENG JG,, YANG HJ, ZOU DH, HE XM
|
Knockdown of vascular endothelial cell growth factor expression sensitizes U251 glioma cells to liposomal paclitaxel and radiation treatment in vitro
|
ETM
|
2012
|
3:181-186
|
|
, Yang HJ, Yu Y, Zou DH, Ling ZQ, He XM, Meng XL
|
Possible role of Pax-6 in promoting breast cancer cell proliferation and tumorigenesis
|
BMB Reports.
|
2011
|
44(9):595-600
|
|
, Yu Yang, Yang HJ
|
Oxaliplatin-Dacarbazine Combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs
|
J Exp Clin Cancer Res
|
2009
|
26(28):119
|
|
, Shi YQ
|
An audit of outcomes in colorectal cancer in China
|
European Journal of Surgical Oncology
|
2006
|
33(2):169-173
|
|